These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

104 related items for PubMed ID: 1913671

  • 1. Down-regulation by interleukin 4 of activation of human alveolar macrophages to the tumoricidal state.
    Nishioka Y, Sone S, Orino E, Nii A, Ogura T.
    Cancer Res; 1991 Oct 15; 51(20):5526-31. PubMed ID: 1913671
    [Abstract] [Full Text] [Related]

  • 2. [Induction of tumor cell killing by human alveolar macrophages and its regulation by IL-4].
    Sone S, Nishioka Y, Nii A, Yanagawa H, Orino E, Mizuno K, Yano S, Ogura T.
    Nihon Kyobu Shikkan Gakkai Zasshi; 1992 Dec 15; 30 Suppl():207-12. PubMed ID: 1306226
    [Abstract] [Full Text] [Related]

  • 3. Interleukin-4 as a potent down-regulator for human alveolar macrophages capable of producing tumour necrosis factor-alpha and interleukin-1.
    Sone S, Yanagawa H, Nishioka Y, Orino E, Bhaskaran G, Nii A, Mizuno K, Heike Y, Ogushi F, Ogura T.
    Eur Respir J; 1992 Feb 15; 5(2):174-81. PubMed ID: 1559582
    [Abstract] [Full Text] [Related]

  • 4. Tumor necrosis factor and IL-1 associated with plasma membranes of activated human monocytes lyse monokine-sensitive but not monokine-resistant tumor cells whereas viable activated monocytes lyse both.
    Ichinose Y, Bakouche O, Tsao JY, Fidler IJ.
    J Immunol; 1988 Jul 15; 141(2):512-8. PubMed ID: 3260254
    [Abstract] [Full Text] [Related]

  • 5. Role of tumor necrosis factor and interleukin 1 in gamma-interferon-promoted activation of mouse tumoricidal macrophages.
    Hori K, Mihich E, Ehrke MJ.
    Cancer Res; 1989 May 15; 49(10):2606-14. PubMed ID: 2496917
    [Abstract] [Full Text] [Related]

  • 6. The incubation of human blood monocytes with tumor necrosis factor-alpha leads to lysis of tumor necrosis factor-sensitive but not resistant tumor cells.
    Nii A, Fidler IJ.
    Lymphokine Res; 1990 May 15; 9(2):113-24. PubMed ID: 2338840
    [Abstract] [Full Text] [Related]

  • 7. Surfactant protein A down-regulates proinflammatory cytokine production evoked by Candida albicans in human alveolar macrophages and monocytes.
    Rosseau S, Hammerl P, Maus U, Günther A, Seeger W, Grimminger F, Lohmeyer J.
    J Immunol; 1999 Oct 15; 163(8):4495-502. PubMed ID: 10510392
    [Abstract] [Full Text] [Related]

  • 8. Additional NO2 exposure induces a decrease in cytokine specific mRNA expression and cytokine release of particle and fibre exposed human alveolar macrophages.
    Drumm K, Buhl R, Kienast K.
    Eur J Med Res; 1999 Feb 25; 4(2):59-66. PubMed ID: 10066641
    [Abstract] [Full Text] [Related]

  • 9. Cultured alveolar macrophages from patients with idiopathic pulmonary fibrosis (IPF) show dysregulation of lipopolysaccharide-induced tumor necrosis factor-alpha (TNF-alpha) and interleukin-10 (IL-10) inductions.
    Freeburn RW, Armstrong L, Millar AB.
    Eur Cytokine Netw; 2005 Feb 25; 16(1):5-16. PubMed ID: 15809201
    [Abstract] [Full Text] [Related]

  • 10. Involvement of the IL-2 receptor gamma-chain (gammac) in the control by IL-4 of human monocyte and macrophage proinflammatory mediator production.
    Bonder CS, Dickensheets HL, Finlay-Jones JJ, Donnelly RP, Hart PH.
    J Immunol; 1998 Apr 15; 160(8):4048-56. PubMed ID: 9558115
    [Abstract] [Full Text] [Related]

  • 11. Differential production of tumor necrosis factor, macrophage colony stimulating factor, and interleukin 1 by human alveolar macrophages.
    Becker S, Devlin RB, Haskill JS.
    J Leukoc Biol; 1989 Apr 15; 45(4):353-61. PubMed ID: 2649630
    [Abstract] [Full Text] [Related]

  • 12. Suppression by interleukin 4 of activation of human blood monocytes to the tumoricidal state.
    Nishioka Y, Sone S, Okubo A, Ogura T.
    Jpn J Cancer Res; 1990 Sep 15; 81(9):936-41. PubMed ID: 2121695
    [Abstract] [Full Text] [Related]

  • 13. IL-4 down-regulates IL-1 and TNF gene expression in human monocytes.
    Essner R, Rhoades K, McBride WH, Morton DL, Economou JS.
    J Immunol; 1989 Jun 01; 142(11):3857-61. PubMed ID: 2785566
    [Abstract] [Full Text] [Related]

  • 14. Interleukin-10 is a potent inhibitor of tumor cytotoxicity by human monocytes and alveolar macrophages.
    Nabioullin R, Sone S, Mizuno K, Yano S, Nishioka Y, Haku T, Ogura T.
    J Leukoc Biol; 1994 Apr 01; 55(4):437-42. PubMed ID: 8145013
    [Abstract] [Full Text] [Related]

  • 15. IL-4 inhibits the costimulatory activity of IL-2 or picolinic acid but not of lipopolysaccharide on IFN-gamma-treated macrophages.
    Cox GW, Chattopadhyay U, Oppenheim JJ, Varesio L.
    J Immunol; 1991 Dec 01; 147(11):3809-14. PubMed ID: 1940368
    [Abstract] [Full Text] [Related]

  • 16. Enhancement of human monocyte tumoricidal activity by recombinant M-CSF.
    Sampson-Johannes A, Carlino JA.
    J Immunol; 1988 Nov 15; 141(10):3680-6. PubMed ID: 3053901
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Coordinated induction of autocrine tumor necrosis factor and interleukin 1 in normal human monocytes and the implications for monocyte-mediated cytotoxicity.
    Smith DM, Lackides GA, Epstein LB.
    Cancer Res; 1990 Jun 01; 50(11):3146-53. PubMed ID: 2334910
    [Abstract] [Full Text] [Related]

  • 19. Recombinant guinea pig CCL5 (RANTES) differentially modulates cytokine production in alveolar and peritoneal macrophages.
    Skwor TA, Cho H, Cassidy C, Yoshimura T, McMurray DN.
    J Leukoc Biol; 2004 Dec 01; 76(6):1229-39. PubMed ID: 15377675
    [Abstract] [Full Text] [Related]

  • 20. Alternatively activated alveolar macrophages in pulmonary fibrosis-mediator production and intracellular signal transduction.
    Pechkovsky DV, Prasse A, Kollert F, Engel KM, Dentler J, Luttmann W, Friedrich K, Müller-Quernheim J, Zissel G.
    Clin Immunol; 2010 Oct 01; 137(1):89-101. PubMed ID: 20674506
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.